Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 3
1955 1
1956 1
1957 1
1960 3
1961 2
1962 4
1963 4
1964 8
1965 4
1966 12
1967 10
1968 17
1969 14
1970 16
1971 12
1972 13
1973 5
1974 13
1975 16
1976 11
1977 26
1978 32
1979 27
1980 23
1981 23
1982 34
1983 33
1984 33
1985 53
1986 46
1987 49
1988 58
1989 61
1990 50
1991 49
1992 71
1993 76
1994 72
1995 56
1996 54
1997 78
1998 70
1999 61
2000 75
2001 65
2002 102
2003 87
2004 95
2005 99
2006 96
2007 92
2008 106
2009 118
2010 121
2011 108
2012 122
2013 109
2014 138
2015 129
2016 122
2017 152
2018 121
2019 125
2020 183
2021 220
2022 239
2023 225
2024 216
2025 219
2026 118

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,452 results

Results by year

Filters applied: . Clear all
Page 1
Hypoxia-induced Wnt5a-secreting fibroblasts promote colon cancer progression.
Harada A, Yasumizu Y, Harada T, Fumoto K, Sato A, Maehara N, Sada R, Matsumoto S, Nishina T, Takeda K, Morii E, Kayama H, Kikuchi A. Harada A, et al. Among authors: harada t. Nat Commun. 2025 Apr 17;16(1):3653. doi: 10.1038/s41467-025-58748-9. Nat Commun. 2025. PMID: 40246836 Free PMC article.
Echocardiographic Diastolic Function Grading in HFpEF: Testing the Updated 2025 ASE Criteria.
Harada T, Sorimachi H, Obokata M, Naser JA, Ibe T, Tada A, Doi S, Kazui S, Murakami T, Kagami K, Reddy YNV, Miranda WR, Manhaeghe L, Nanayakkara S, Janssen-Telders C, Handoko ML, Verbrugge FH, Kaye DM, Borlaug BA. Harada T, et al. J Am Coll Cardiol. 2026 Mar 17;87(10):1261-1275. doi: 10.1016/j.jacc.2025.11.024. Epub 2026 Jan 14. J Am Coll Cardiol. 2026. PMID: 41532943
IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancer.
Ibusuki R, Iwama E, Shimauchi A, Kawano H, Mizusaki S, Nakamura S, Miyazaki Y, Inutsuka Y, Hashisako M, Harada T, Tsuchiya-Kawano Y, Tsutsumi H, Nakanishi T, Nakagaki N, Koga Y, Kimura S, Mashimoto S, Shibahara D, Otsubo K, Yoneshima Y, Tanaka K, Oda Y, Okamoto I. Ibusuki R, et al. Among authors: harada t. Mol Cancer. 2025 Oct 28;24(1):272. doi: 10.1186/s12943-025-02493-6. Mol Cancer. 2025. PMID: 41152910 Free PMC article.
Efficacy and safety of the combination of estetrol 15 mg/drospirenone 3 mg in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: a multicenter, placebo-controlled, double-blind, randomized study.
Harada T, Kobayashi T, Hirakawa A, Takayanagi T, Nogami M, Mochiyama T, Hirayama M, Foidart JM, Osuga Y. Harada T, et al. Fertil Steril. 2024 Nov;122(5):894-901. doi: 10.1016/j.fertnstert.2024.07.011. Epub 2024 Jul 14. Fertil Steril. 2024. PMID: 39002879 Free article. Clinical Trial.
Role of HAUS7 as a DOCK3 binding partner in facilitating axon regeneration.
Kiyota N, Shinozaki Y, Guo X, Kimura A, Kawamura K, Nishijima E, Honda S, Harada C, Nakazawa T, Namekata K, Harada T. Kiyota N, et al. Among authors: harada t. Sci Adv. 2025 Jul 25;11(30):eadq7105. doi: 10.1126/sciadv.adq7105. Epub 2025 Jul 25. Sci Adv. 2025. PMID: 40712007 Free PMC article.
An evidence-based tool for screening for heart failure with preserved ejection fraction in primary care: The BREATH2 score.
Saito Y, Kagiyama N, Harada T, Kaneko T, Kagami K, Dotare T, Yuasa N, Sato E, Sorimachi H, Murata A, Kawagoshi M, Nishiya Y, Yasui A, Okumura Y, Minamino T, Ishii H, Obokata M. Saito Y, et al. Among authors: harada t. J Cardiol. 2025 Sep;86(3):264-271. doi: 10.1016/j.jjcc.2025.03.018. Epub 2025 Apr 3. J Cardiol. 2025. PMID: 40187528 Free article.
Domain-adaptive semi-supervised learning for efficient rare pathological lesion detection with minimal annotation.
Matsui I, Matsumoto A, Imai A, Okushima H, Niioka H, Abe M, Tamai N, Nagasu H, Kanda E, Uchino E, Sofue T, Imasawa T, Yano Y, Kinashi H, Miyoshi KI, Harada T, Nagasawa Y, Fujimoto K, Kurokawa Y, Kato S, Kaseda R, Koizumi M, Kusunoki Y, Ohya M, Kawazoe Y, Abe H, Matsukuma Y, Kosugi T, Ueda Y, Fujii N, Takeji M, Suzuki A, Nagatoya K, Oka K, Ando Y, Izumi M, Komiya T, Tsukamoto T, Mimura I, Kuragano T, Nakano T, Tsuruya K, Ito Y, Minamino T, Yamaguchi O, Yamamoto S, Komaba H, Furuichi K, Fukami K, Araki SI, Masaki T, Tsuboi N, Yokoyama H, Shimizu A, Ushiku T, Maruyama S, Yanagita M, Nangaku M, Yamamoto R, Inoue K, Isaka Y. Matsui I, et al. Among authors: harada t. NPJ Digit Med. 2025 Nov 23;8(1):778. doi: 10.1038/s41746-025-02160-6. NPJ Digit Med. 2025. PMID: 41276625 Free PMC article.
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non-small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102).
Shiraishi Y, Shimose T, Tachihara M, Tsuchiya-Kawano Y, Morinaga R, Inoue H, Toi Y, Yamada T, Yamaguchi M, Kashiwabara K, Tobino K, Ishii H, Sakata Y, Inaba M, Nakashima K, Chibana K, Fukui T, Izumi M, Saito R, Ishii H, Omori S, Ogusu S, Furuyama K, Miura S, Harada T, Okamoto I. Shiraishi Y, et al. Among authors: harada t. Eur J Cancer. 2025 Oct 16;229:115779. doi: 10.1016/j.ejca.2025.115779. Epub 2025 Sep 12. Eur J Cancer. 2025. PMID: 40961811 Free article. Clinical Trial.
Neuroimaging Features of Cytokine-related Diseases.
Kurokawa M, Kurokawa R, Baba A, Gomi T, Cho S, Yoshioka K, Harada T, Kim J, Emile P, Abe O, Moritani T. Kurokawa M, et al. Among authors: harada t. Radiographics. 2024 Jun;44(6):e230069. doi: 10.1148/rg.230069. Radiographics. 2024. PMID: 38696321 Review.
Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED).
Shiraishi Y, Shimose T, Tsuchiya-Kawano Y, Ishii H, Mizuno K, Toi Y, Daga H, Ito K, Iyama S, Taniguchi H, Morinaga R, Harada T, Inoue H, Misumi Y, Naoki K, Tobino K, Izumi M, Omori S, Tsumura S, Yamanaka Y, Sakata Y, Miura S, Mizutani H, Oki M, Iwama E, Otsubo K, Okamoto I. Shiraishi Y, et al. Among authors: harada t. ESMO Open. 2025 Jul;10(7):105325. doi: 10.1016/j.esmoop.2025.105325. Epub 2025 Jul 3. ESMO Open. 2025. PMID: 40614659 Free PMC article. Clinical Trial.
4,452 results